#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pustular psoriasis Hypochondroplasia Hyperinsulinism Neuroblastoma Narcolepsy Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Acquired ATTR amyloidosis Spinal cord injury cervical Myelofibrosis Extraskeletal ossification Gastrointestinal neuroendocrine tumour Undifferentiated sarcoma Heart disease congenital Breast cancer Heavy menstrual bleeding More trials…

    Learn about Rare Diseases

    Retinoblastoma – Life with Disease VEXAS syndrome – Treatment Medulloblastoma recurrent – Diagnostics Castleman’s disease – Life with Disease Alport’s syndrome – Basic Information Small intestine leiomyosarcoma Hereditary angioedema – Life with Disease Bronchopulmonary dysplasia – Life with Disease Haemophilia B with anti factor IX – Diagnostics Encephalitis autoimmune – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Timbetasin Acetate BNT327 Afamelanotide Gskvx000000009151 Netupitant Human Immunoglobulin G Prax-628 Cenerimod Triheptanoin TIL CELLS Filgrastim Dermatophagoides Pteronyssinus Linagliptin Tofersen VMX-C001 Emrusolmin Cevostamab ICEF15 M1P Dipotassium Salt Sacituzumab Govitecan More therapies…

    Learn about Your Condition

    Hepatic neoplasm Tuberous sclerosis complex Brain neoplasm Affective disorder Neurofibrosarcoma Medication overuse headache Osteosarcoma recurrent Penile cancer Allergic respiratory disease Eructation Inguinal hernia Renal failure Implantation complication Anal incontinence Acquired ATTR amyloidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on Melatonin for Patients with Chronic Back Pain

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Melatonin
    Denmark

  • Study on the Effectiveness and Safety of Infigratinib for Children Aged 3 to 17 with Achondroplasia

    Not recruiting

    3 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Infigratinib
    France Germany Italy Norway Spain

  • Study on the Safety of Allocetra for Patients with Knee Osteoarthritis

    Not recruiting

    1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Allogeneic Peripheral Blood Mononuclear Cells Induced To An Early Apoptotic State
    Denmark

  • Study on Lidocaine, Ropivacaine, and Epinephrine for Patients Undergoing Hand Surgery with Ultrasound-Guided Nerve Block

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Epinephrine
    • Lidocaine Hydrochloride
    Denmark

  • Study on the Effects of NX210c and Glucose in Adults with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • H-L-Tryphophanyl-L-Seryl-Glycyl-L-Tryptophanyl-L-Seryl-L-Seryl-L-Cysteinyl-L-Seryl-L-Arginyl-L-Seryl-L-Cysteinyl-Glycyl-Oh (Disulfide Bond), Acetate Salt
    • Glucose
    France

  • Study on Tofacitinib for Achieving Remission in Early Psoriatic Arthritis Patients Without Prior DMARD Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tofacitinib
    Belgium
Previous Page
1 … 51 52 53 54 55 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!